- Home
- ELSE vs CLRB Comparison
ELSE vs CLRB Comparison
Compare ELSE & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELSE | CLRB |
|---|---|---|
| Founded | 1968 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5M | 12.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ELSE | CLRB |
|---|---|---|
| Price | $4.30 | $3.35 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.8K | ★ 34.5K |
| Earning Date | 03-18-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $9,787,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $36.17 | ★ N/A |
| Revenue Growth | ★ 5.36 | N/A |
| 52 Week Low | $3.65 | $2.45 |
| 52 Week High | $5.29 | $20.60 |
Technical Indicators
Market Signals| Indicator | ELSE | CLRB |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 45.85 |
| Support Level | $4.23 | $3.14 |
| Resistance Level | $4.40 | $3.42 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 15.96 | 46.98 |
Price Performance
Historical ComparisonAbout ELSE Electro-Sensors Inc.
Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.